BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mattsson-Carlgren N, Palmqvist S, Blennow K, Hansson O. Increasing the reproducibility of fluid biomarker studies in neurodegenerative studies. Nat Commun 2020;11:6252. [PMID: 33288742 DOI: 10.1038/s41467-020-19957-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Landry V, Coburn P, Kost K, Liu X, Li-jessen NYK. Diagnostic Accuracy of Liquid Biomarkers in Airway Diseases: Toward Point-of-Care Applications. Front Med 2022;9:855250. [DOI: 10.3389/fmed.2022.855250] [Reference Citation Analysis]
2 Schalkamp AK, Rahman N, Monzón-Sandoval J, Sandor C. Deep phenotyping for precision medicine in Parkinson's disease. Dis Model Mech 2022;15:dmm049376. [PMID: 35647913 DOI: 10.1242/dmm.049376] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials. The Lancet Neurology 2022. [DOI: 10.1016/s1474-4422(22)00168-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Varesi A, Carrara A, Pires VG, Floris V, Pierella E, Savioli G, Prasad S, Esposito C, Ricevuti G, Chirumbolo S, Pascale A. Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview. Cells 2022;11:1367. [PMID: 35456047 DOI: 10.3390/cells11081367] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Soelter TM, Whitlock JH, Williams AS, Hardigan AA, Lasseigne BN. Nucleic acid liquid biopsies in Alzheimer's disease: current state, challenges, and opportunities. Heliyon 2022;8:e09239. [PMID: 35469332 DOI: 10.1016/j.heliyon.2022.e09239] [Reference Citation Analysis]
6 Murueta-goyena A, Cipriani R, Carmona-abellán M, Acera M, Ayo N, del Pino R, Tijero B, Fernández T, Gabilondo I, Zallo F, Matute C, Sánchez-pernaute R, Khurana V, Cavaliere F, Capetillo-zarate E, Gómez-esteban JC. Characterization of molecular biomarkers in cerebrospinal fluid and serum of E46K-SNCA mutation carriers. Parkinsonism & Related Disorders 2022. [DOI: 10.1016/j.parkreldis.2022.01.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Leuzy A, Mattsson-Carlgren N, Palmqvist S, Janelidze S, Dage JL, Hansson O. Blood-based biomarkers for Alzheimer's disease. EMBO Mol Med 2021;:e14408. [PMID: 34859598 DOI: 10.15252/emmm.202114408] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
8 Fan Q, Gao Y, Mazur F, Chandrawati R. Nanoparticle-based colorimetric sensors to detect neurodegenerative disease biomarkers. Biomater Sci 2021;9:6983-7007. [PMID: 34528639 DOI: 10.1039/d1bm01226f] [Reference Citation Analysis]
9 Nielsen JE, Honoré B, Vestergård K, Maltesen RG, Christiansen G, Bøge AU, Kristensen SR, Pedersen S. Shotgun-based proteomics of extracellular vesicles in Alzheimer's disease reveals biomarkers involved in immunological and coagulation pathways. Sci Rep 2021;11:18518. [PMID: 34531462 DOI: 10.1038/s41598-021-97969-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Ashton NJ, Blennow K, Zetterberg H. Spitting image: can saliva biomarkers reflect Alzheimer's disease? EBioMedicine 2021;68:103437. [PMID: 34134088 DOI: 10.1016/j.ebiom.2021.103437] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Palmqvist S, Tideman P, Cullen N, Zetterberg H, Blennow K, Dage JL, Stomrud E, Janelidze S, Mattsson-Carlgren N, Hansson O; Alzheimer’s Disease Neuroimaging Initiative. Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures. Nat Med 2021;27:1034-42. [PMID: 34031605 DOI: 10.1038/s41591-021-01348-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 60] [Article Influence: 6.0] [Reference Citation Analysis]
12 Keep RF, Jones HC, Drewes LR. Brain Barriers and brain fluids research in 2020 and the fluids and barriers of the CNS thematic series on advances in in vitro modeling of the blood-brain barrier and neurovascular unit. Fluids Barriers CNS 2021;18:24. [PMID: 34020685 DOI: 10.1186/s12987-021-00258-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
13 Bellomo G, Indaco A, Chiasserini D, Maderna E, Paolini Paoletti F, Gaetani L, Paciotti S, Petricciuolo M, Tagliavini F, Giaccone G, Parnetti L, Di Fede G. Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders. Front Neurosci 2021;15:647783. [PMID: 33867925 DOI: 10.3389/fnins.2021.647783] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Campese N, Palermo G, Del Gamba C, Beatino MF, Galgani A, Belli E, Del Prete E, Della Vecchia A, Vergallo A, Siciliano G, Ceravolo R, Hampel H, Baldacci F. Progress regarding the context-of-use of tau as biomarker of Alzheimer's disease and other neurodegenerative diseases. Expert Rev Proteomics 2021;18:27-48. [PMID: 33545008 DOI: 10.1080/14789450.2021.1886929] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Meldolesi J. News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases. Biomedicines 2021;9:252. [PMID: 33806691 DOI: 10.3390/biomedicines9030252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Smith GS, Kuwabara H, Nandi A, Gould NF, Nassery N, Savonenko A, Joo JH, Kraut M, Brasic J, Holt DP, Hall AW, Mathews WB, Dannals RF, Avramopoulos D, Workman CI. Molecular imaging of beta-amyloid deposition in late-life depression. Neurobiol Aging 2021;101:85-93. [PMID: 33592548 DOI: 10.1016/j.neurobiolaging.2021.01.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]